Illustration of nanotechnology-based drug products, leukocytes, platelets, and complement.

FREDERICK, Md. -- A new technical service offered by the Frederick National Laboratory for Cancer Research will help researchers screen their nanoformulations for the risk of causing infusion reactions. 

Pages